Tag
Gilead Sciences
2 articles
Dr Reddy's Confirms HIV Drug License with Gilead
Dr. Reddy's confirms a voluntary licensing agreement with Gilead Sciences for an investigational once-yearly HIV prevention drug, lenacapavir.
The disclosure is a clarification to the NSE regarding a
Dr. Reddy's Confirms Gilead HIV Drug Licensing Agreement
Dr. Reddy's confirms a news report about securing a voluntary license from Gilead Sciences for an investigational once-yearly HIV prevention drug.
The disclosure is a clarification to stock exchanges